Posted innews Oncology Otorhinolaryngology
Proton Beam vs IMRT for Olfactory Neuroblastoma: Too Little Data for a Definitive Answer — What the New Propensity-Matched Cohort Tells Us
A multi-institutional propensity-matched cohort found no definitive differences in oncologic outcomes or grade ≥2 radiotherapy toxicities between adjuvant proton beam radiotherapy and IMRT for olfactory neuroblastoma, but estimates were imprecise and underpowered.